The price of Pi Network has taken a significant hit following OKX’s decision to discontinue margin trading for PI/USDT pairs, causing panic selling and heightened volatility. This move […]
OKX to Delist JST Futures, Impacting Traders
The cryptocurrency market is known for its constant shifts in listings, partnerships, and delistings. Recent announcements from a major exchange have highlighted the impact of this dynamic on […]
Windtree Therapeutics to Be Delisted from NASDAQ Amidst Declining Stock and Treasury Strategy
Healthcare company Windtree Therapeutics will be delisted from the NASDAQ stock market by the end of this week after failing to meet listing requirements. The company’s failure to […]
WindTree Risks Nasdaq Delisting Amid Concerns over Non-Compliance
WindTree Therapeutics, a biopharmaceutical company linked to the BNB treasury, faces potential delisting from the Nasdaq stock exchange due to non-compliance with listing requirements. The Nasdaq has issued […]
Windtree Faces Demise From Nasdaq Delisting Over Bid Price Rule Failure
Nasdaq has announced plans to remove Windtree Therapeutics (WINT) from trading, citing non-compliance with listing regulations. The company’s failure to maintain a minimum bid price above $1 per […]
Windtree Therapeutics Faces Delisting After Major BNB Investment
Nasdaq has delisted Windtree Therapeutics, citing a 77% stock decline caused by the company’s decision to invest heavily in Binance Coin (BNB). CEO Jed Latkin confirmed these reports […]
BNB Treasury Strategy Fails: Biotech Firm Windtree Loses 77% After Nasdaq Delisting
Windtree Therapeutics, a biotechnology company that adopted a BNB treasury strategy last month, experienced a significant market downturn after being delisted from the Nasdaq. The company was notified […]
Windtree Therapeutics Delists from Nasdaq after BNB Treasury Strategy Fails
Windtree Therapeutics’ Nasdaq listing was terminated on August 21, 2025, following a failed pivot to a $700 million BNB-focused treasury. The move resulted in a drastic decline of […]
Windtree Therapeutics Delisted: Delisting Highlights Challenges of Crypto-Centric Strategy
Windtree Therapeutics, facing financial struggles despite heavy investments in cryptocurrency, will be delisted from Nasdaq on August 21st, 2025. The company’s strategy to shift its treasury towards cryptocurrencies […]
Windtree Therapeutics Faces Delisting from Nasdaq, Shares Plunge Amidst Financial Struggles
Windtree Therapeutics is facing delisting from the Nasdaq Capital Market after failing to meet a minimum $1 bid price requirement for 30 consecutive business days. The company’s shares […]
Windtree Therapeutics Delists from Nasdaq: What You Need to Know
Nasdaq has announced that Windtree Therapeutics will be delisted from the exchange, effective August 21, 2025. This decision comes due to the company failing to meet the minimum […]
Windtree Therapeutics Delisting: Nasdaq Rule Violation Leads to Market Volatility
The biotechnology firm, Windtree Therapeutics, has been delisted from the Nasdaq Stock Exchange due to failing to maintain a minimum bid price of $1 for 30 consecutive business […]
Nasdaq Delisting Looms for Windtree as BNB Treasury Portfolio Under Scrutiny
Windtree, a biotech firm that pivoted to a BNB treasury model, faces imminent delisting from the Nasdaq on August 21st. The company’s stock price has plummeted over the […]
Nasdaq Delists Windtree Therapeutics; Stock Plummets 76%
Windtree Therapeutics, a company focused on developing treatments for cardiovascular diseases, will be delisted from the Nasdaq Stock Market on August 21, 2025. This follows noncompliance with listing […]
Binance Removes Three Spot Trading Pairs: August Delisting and New Leverage Options
Binance has announced the removal of three spot trading pairs from its platform, effective August 15th. This action follows the exchange’s regular review process, which aims to optimize […]